Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Sponsorship Statement: This continuing medical education activity is sponsored by 
.
Support Statement: There is no commercial support for this activity. The content contained in this activity was developed from the live activity that was supported by an educational grant from 
.
Target Audience: This program is designed for retina specialists, comprehensive ophthalmologists, and other healthcare professionals involved in the treatment of patients with retina disorders.
Learning Objectives: At the conclusion of this activity, participants should be able to:
- Identify the clinical, angiographic, ultrasonographic, prognostic, and intraoperative features that indicate vitreomacular traction.
- Assess ocular damage caused by vitreomacular traction and retinal diseases that may progress from an incomplete posterior vitreous detachment.
- Evaluate new clinical evidence on options for management of patients with vitreomacular traction.
Course Chair:
Jay S. Duker, MD
Director, New England Eye Center
Professor and Chairman
Department of Ophthalmology
Tufts Medical Center
Tufts University School of Medicine
Boston, Massachusetts
Faculty:
Allen C. Ho, MD
Professor of Ophthalmology
Wills Eye Institute
Mid Atlantic Retina
Philadelphia, Pennsylvania
Carl D. Regillo, MD
Wills Eye Institute
Professor of Ophthalmology
Thomas Jefferson University
Philadelphia, Pennsylvania
External Reviewer:
Michael W. Stewart, MD
Continuing Medical Education Information:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of release, December 12, 2012 to December 11, 2013.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, watch the lecture, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM certificate that will be e-mailed to the participant.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Jay S. Duker, MD
Research Support: Carl Zeiss Meditec, OptoVue, Topcon Medical Systems
Scientific Advisory Board: Paloma Pharmaceuticals
Consultant: Alcon Laboratories, Inc., Genentech, Neovista, Novartis Pharmaceuticals Corporation, QLT Phototherapeutics, Inc., EMD Serono, ThromboGenics
Stock Holder: EyeNetra, Hemera Biosciences, Ophthotech
Allen C. Ho, MD
Consulting Fees: Alcon, Allergan, Centocor/Johnson and Johnson, Genentech, NeoVista, Merck, Ophthotech, Oraya, Paloma, PRN, QLT, Regeneron, ThromboGenics
Fees for Non-CME Services: Alcon, Centocor/Johnson and Johnson, Genentech, QLT, PRN, Ophthotech, NeoVista, GlaxoSmithKline
Contracted Research: Alcon, Allergan, Genentech, NEI/NIH, NeoVista, Ophthotech, Oraya, PRN, QLT, Regeneron, Second Sight
Carl D. Regillo, MD
Consulting Fees: Genentech, Regeneron, Alimera, Allergan
Contracted Research: Genentech, Regeneron, Alimera, Allergan
External Reviewer reports the following relationship(s):
Michael W. Stewart, MD
Consulting Fees: Regeneron, Allergan
Contracted Research: Regeneron
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright© 2012 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.